Je was op zoek naar: intralstelin (Lithouws - Engels)

intralstelin farmakokinetika
intracellular pharmacokinetics

lamivudinas gali slopinti intralstelin zalcitabino fosforilinim, kai sie du vaistai vartojami kartu.
8 lamivudine may inhibit the intracellular phosphorylation of zalcitabine when the two medicinal products are used concurrently.

lamivudinas gali slopinti intralstelin zalcitabino fosforilinim, kai sie du vaistiniai preparatai skiriami kartu.
lamivudine may inhibit the intracellular phosphorylation of zalcitabine when the two medicinal products are used concurrently.

mycobacterium avium intralstelin kompleks reikia gydyti ne klaritromicinu, kadangi tokiu atveju aktyvus jo metabolitas yra neveiksmingas.
however, alternative therapy to clarithromycin should be considered when treating a patient for mycobacterium avium-intracellulare complex, as the active metabolite is not effective in this instance.

kiekvienu tokiu atveju turt bti vertinama galima dozs sumazinimo nauda ir galima rizika (mazesn intralstelin vaisto koncentracija) .
the possible benefits of a dose reduction should be balanced in each case against the risks -which may result from this measure (lower intracellular concentrations) .

replagal neturt bti skiriamas kartu su chlorochinu, amiodaronu, benochinu ar gentamicinu, nes sios medziagos gali slopinti intralstelin -galaktozidazs aktyvum.
replagal should not be co-administered with chloroquine, amiodarone, benoquin or gentamicin since these substances have the potential to inhibit intra-cellular -galactosidase activity.

intralstelin farmakokinetika neproliferuojanciose zmogaus periferinio kraujo vienbranduolse lstelse (pkvl) tenofoviro difosfato pusins eliminacijos periodas trunka mazdaug 50 valand, o fitohemagliutininu stimuliuotose analogiskose lstelse ­ mazdaug 10 valand.
intracellular pharmacokinetics in non-proliferating human peripheral blood mononuclear cells (pbmcs) the half-life of tenofovir diphosphate was found to be approximately 50 hours, whereas the half-life in phytohaemagglutinin-stimulated pbmcs was found to be approximately 10 hours.

intralstelin farmakokinetika: klinikinio tyrimo duomenimis emtricitabino trifosfato intralstelinis pusins eliminacijos periodas periferinio kraujo mononuklearuose buvo 39 valandos.intralstelinis trifosfato lygis didjo didjant dozei, taciau skiriant 200 mg ar didesnes dozes buvo pasiektas plato.
intracellular pharmacokinetics:in a clinical study, the intracellular half-life of emtricitabine-triphosphate in peripheral blood mononuclear cells was 39 hours.

repaglinido farmakokinetika yra apibdinama vidutiniu biologiniu pasisavinimu ­ 63% (cv 11%) , mazu pasiskirstymo triu ­ 30 l (atitinkantis pasiskirstym intralsteliniame skystyje) ir greitu pasisalinimu is kraujo.
repaglinide pharmacokinetics are characterised by a mean absolute bioavailability of 63% (cv 11%) , low volume of distribution, 30 l (consistent with distribution into intracellular fluid) , and rapid elimination from the blood.